ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · Real-Time Price · USD
1.590
+1.230 (341.05%)
At close: Apr 1, 2025, 4:00 PM
2.190
+0.600 (37.74%)
After-hours: Apr 1, 2025, 7:59 PM EDT
ReShape Lifesciences Market Cap
ReShape Lifesciences has a market cap or net worth of $5.26 million as of April 1, 2025. Its market cap has increased by 37.86% in one year.
Market Cap
5.26M
Enterprise Value
6.11M
1-Year Change
37.86%
Ranking
Category
Stock Price
$1.59
Market Cap Chart
Since August 22, 2018, ReShape Lifesciences's market cap has increased from $3.45M to $5.26M, an increase of 52.22%. That is a compound annual growth rate of 6.56%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 741.66B |
UnitedHealth Group | 479.08B |
Johnson & Johnson | 399.65B |
AbbVie | 370.64B |
Novo Nordisk | 302.16B |
Abbott Laboratories | 230.06B |
Merck & Co. | 226.74B |
AstraZeneca | 225.46B |